Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts

Bone

Volumn 52, Issue 1, 2013, Pages 145-156

  Zhang, Rongrong ^a   Oyajobi, Babatunde O ^b   Harris, Stephen E ^c   Chen, Di ^d   Tsao, Christopher ^e   Deng, Hong Wen ^a   Zhao, Ming ^a,f  

^a TULANE UNIVERSITY   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d RUSH UNIVERSITY   (United States)

^e University of Texas at San Antonio   (United States)

^f Tulane University   (United States)

Author keywords

BMP; Gene expression; Osteogenesis; Wnt catenin

Indexed keywords

BETA CATENIN; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; BONE MORPHOGENETIC PROTEIN 2; DICKKOPF 1 PROTEIN; F BOX PROTEIN; F BOX WD40 REPEAT PROTEIN 1; INHIBITOR OF BETA CATENIN AND TRANSCRIPTION FACTOR; INHIBITOR PROTEIN; MESSENGER RNA; SECRETED FRIZZLED RELATED PROTEIN 4; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CELL LINE; CELLS, CULTURED; DNA PRIMERS; MICE; OSTEOBLASTS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84870318883     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.09.029     Document Type: Article

References (80)

1. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766.
2. Wozney J.M., Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 1998, 26-37.
3. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
4. Chen D., Harris M.A., Rossini G., Dunstan C.R., Dallas S.L., Feng J.Q., et al. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 1997, 60:283-290.
5. Harris S.E., Guo D., Harris M.A., Krishnaswamy A., Lichtler A. Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: role of Dlx2 and Dlx5 transcription factors. Front Biosci 2003, 8:s1249-s1265.
6. Zhao M., Harris S.E., Horn D., Geng Z., Nishimura R., Mundy G.R., et al. Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol 2002, 157:1049-1060.
7. Ghosh-Choudhury N., Harris M.A., Feng J.Q., Mundy G.R., Harris S.E. Expression of the BMP 2 gene during bone cell differentiation. Crit Rev Eukaryot Gene Expr 1994, 4:345-355.
8. Harris S.E., Sabatini M., Harris M.A., Feng J.Q., Wozney J., Mundy G.R. Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells. J Bone Miner Res 1994, 9:389-394.
9. Arikawa T., Omura K., Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 2004, 200:400-406.
10. Feng J.Q., Xing L., Zhang J.H., Zhao M., Horn D., Chan J., et al. NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 2003, 278:29130-29135.
11. Garrett I.R., Chen D., Gutierrez G., Zhao M., Escobedo A., Rossini G., et al. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest 2003, 111:1771-1782.
12. Harris S.E., Bonewald L.F., Harris M.A., Sabatini M., Dallas S., Feng J.Q., et al. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 1994, 9:855-863.
13. Zhao M., Ko S.Y., Liu J.H., Chen D., Zhang J., Wang B., et al. Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2. Mol Cell Biol 2009, 29:1291-1305.
14. Zhao M., Qiao M., Harris S.E., Chen D., Oyajobi B.O., Mundy G.R. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol Cell Biol 2006, 26:6197-6208.
15. Zhou S., Turgeman G., Harris S.E., Leitman D.C., Komm B.S., Bodine P.V., et al. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol Endocrinol 2003, 17:56-66.
16. Liu H., Zhang R., Ko S.Y., Oyajobi B.O., Papasian C.J., Deng H.W., et al. Microtubule assembly affects bone mass by regulating both osteoblast and osteoclast functions: stathmin deficiency produces an osteopenic phenotype in mice. J Bone Miner Res 2011, 26:2052-2067.
17. Zhang R., Edwards J.R., Ko S.Y., Dong S., Liu H., Oyajobi B.O., et al. Transcriptional regulation of BMP2 expression by the PTH-CREB signaling pathway in osteoblasts. PLoS One 2011, 6:e20780.
18. Feng J.Q., Chen D., Ghosh-Choudhury N., Esparza J., Mundy G.R., Harris S.E. Bone morphogenetic protein 2 transcripts in rapidly developing deer antler tissue contain an extended 5' non-coding region arising from a distal promoter. Biochim Biophys Acta 1997, 1350:47-52.
19. Ghosh-Choudhury N., Abboud S.L., Nishimura R., Celeste A., Mahimainathan L., Choudhury G.G. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 2002, 277:33361-33368.
20. Ghosh-Choudhury N., Choudhury G.G., Harris M.A., Wozney J., Mundy G.R., Abboud S.L., et al. Autoregulation of mouse BMP-2 gene transcription is directed by the proximal promoter element. Biochem Biophys Res Commun 2001, 286:101-108.
21. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002, 346:1513-1521.
22. Clement-Lacroix P., Ai M., Morvan F., Roman-Roman S., Vayssiere B., Belleville C., et al. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci U S A 2005, 102:17406-17411.
23. Little R.D., Carulli J.P., Del Mastro R.G., Dupuis J., Osborne M., Folz C., et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002, 70:11-19.
24. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:513-523.
25. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005, 8:739-750.
26. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., et al. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 2005, 280:21162-21168.
27. Morvan F., Boulukos K., Clement-Lacroix P., Roman Roman S., Suc-Royer I., Vayssiere B., et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 2006, 21:934-945.
28. Ellwanger K., Saito H., Clement-Lacroix P., Maltry N., Niedermeyer J., Lee W.K., et al. Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. Mol Cell Biol 2008, 28:4875-4882.
29. Hill T.P., Spater D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005, 8:727-738.
30. Bain G., Muller T., Wang X., Papkoff J. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun 2003, 301:84-91.
31. Glass D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005, 8:751-764.
32. Rawadi G., Vayssiere B., Dunn F., Baron R., Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 2003, 18:1842-1853.
33. Fukuda T., Kokabu S., Ohte S., Sasanuma H., Kanomata K., Yoneyama K., et al. Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism. Differentiation 2010, 80:46-52.
34. Kusu N., Laurikkala J., Imanishi M., Usui H., Konishi M., Miyake A., et al. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem 2003, 278:24113-24117.
35. Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005, 280:19883-19887.
36. Winkler D.G., Sutherland M.S., Ojala E., Turcott E., Geoghegan J.C., Shpektor D., et al. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins. J Biol Chem 2005, 280:2498-2502.
37. Abreu J.G., Ketpura N.I., Reversade B., De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 2002, 4:599-604.
38. Mercurio S., Latinkic B., Itasaki N., Krumlauf R., Smith J.C. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 2004, 131:2137-2147.
39. Misra K., Matise M.P. A critical role for sFRP proteins in maintaining caudal neural tube closure in mice via inhibition of BMP signaling. Dev Biol 2010, 337:74-83.
40. Piccolo S., Agius E., Leyns L., Bhattacharyya S., Grunz H., Bouwmeester T., et al. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature 1999, 397:707-710.
41. Edlund S., Lee S.Y., Grimsby S., Zhang S., Aspenstrom P., Heldin C.H., et al. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol 2005, 25:1475-1488.
42. Eivers E., Demagny H., Choi R.H., De Robertis E.M. Phosphorylation of Mad controls competition between wingless and BMP signaling. Sci Signal 2011, 4:ra68.
43. Eivers E., Demagny H., De Robertis E.M. Integration of BMP and Wnt signaling via vertebrate Smad1/5/8 and Drosophila Mad. Cytokine Growth Factor Rev 2009, 20:357-365.
44. Fuentealba L.C., Eivers E., Ikeda A., Hurtado C., Kuroda H., Pera E.M., et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007, 131:980-993.
45. Liu Z., Tang Y., Qiu T., Cao X., Clemens T.L. A dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. J Biol Chem 2006, 281:17156-17163.
46. Tang Y., Liu Z., Zhao L., Clemens T.L., Cao X. Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J Biol Chem 2008, 283:23956-23963.
47. Chakladar A., Dubeykovskiy A., Wojtukiewicz L.J., Pratap J., Lei S., Wang T.C. Synergistic activation of the murine gastrin promoter by oncogenic Ras and beta-catenin involves SMAD recruitment. Biochem Biophys Res Commun 2005, 336:190-196.
48. Hu M.C., Rosenblum N.D. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development 2005, 132:215-225.
49. Hussein S.M., Duff E.K., Sirard C. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 2003, 278:48805-48814.
50. Labbe E., Letamendia A., Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 2000, 97:8358-8363.
51. Lei S., Dubeykovskiy A., Chakladar A., Wojtukiewicz L., Wang T.C. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways. J Biol Chem 2004, 279:42492-42502.
52. Sakai D., Tanaka Y., Endo Y., Osumi N., Okamoto H., Wakamatsu Y. Regulation of Slug transcription in embryonic ectoderm by beta-catenin-Lef/Tcf and BMP-Smad signaling. Dev Growth Differ 2005, 47:471-482.
53. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
54. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
55. Tago K., Nakamura T., Nishita M., Hyodo J., Nagai S., Murata Y., et al. Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev 2000, 14:1741-1749.
56. Kitagawa M., Hatakeyama S., Shirane M., Matsumoto M., Ishida N., Hattori K., et al. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 1999, 18:2401-2410.
57. Zhao M., Qiao M., Oyajobi B.O., Mundy G.R., Chen D. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 2003, 278:27939-27944.
58. Li W., Yu B., Li M., Sun D., Hu Y., Zhao M., et al. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha. Biochem Biophys Res Commun 2010, 391:1228-1233.
59. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999, 286:1946-1949.
60. Mohammad K.S., Chirgwin J.M., Guise T.A. Assessing new bone formation in neonatal calvarial organ cultures. Methods Mol Biol 2008, 455:37-50.
61. Clines G.A., Mohammad K.S., Bao Y., Stephens O.W., Suva L.J., Shaughnessy J.D., et al. Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation. Mol Endocrinol 2007, 21:486-498.
62. Hill T.P., Taketo M.M., Birchmeier W., Hartmann C. Multiple roles of mesenchymal beta-catenin during murine limb patterning. Development 2006, 133:1219-1229.
63. Kim J.S., Crooks H., Dracheva T., Nishanian T.G., Singh B., Jen J., et al. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res 2002, 62:2744-2748.
64. Theisen H., Syed A., Nguyen B.T., Lukacsovich T., Purcell J., Srivastava G.P., et al. Wingless directly represses DPP morphogen expression via an armadillo/TCF/Brinker complex. PLoS One 2007, 2:e142.
65. Liu H., Zhang R., Chen D., Oyajobi B.O., Zhao M. Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation. J Cell Physiol 2011, 227:952-963.
66. He B., Lee A.Y., Dadfarmay S., You L., Xu Z., Reguart N., et al. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Cancer Res 2005, 65:743-748.
67. Muley A., Majumder S., Kolluru G.K., Parkinson S., Viola H., Hool L., et al. Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol 2010, 176:1505-1516.
68. Gottardi C.J., Gumbiner B.M. Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions. Am J Physiol Cell Physiol 2004, 286:C747-C756.
69. Kim Y.J., Kim J.T., Bae Y.C., Suh K.T., Jung J.S. ICAT participates in proliferation and osteogenic differentiation of human adipose tissue-derived mesenchymal stem cell. Life Sci 2008, 83:851-858.
70. Chen S., Guttridge D.C., You Z., Zhang Z., Fribley A., Mayo M.W., et al. Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol 2001, 152:87-96.
71. Hart M., Concordet J.P., Lassot I., Albert I., del los Santos R., Durand H., et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999, 9:207-210.
72. Jiang J., Struhl G. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 1998, 391:493-496.
73. Latres E., Chiaur D.S., Pagano M. The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 1999, 18:849-854.
74. Liu C., Kato Y., Zhang Z., Do V.M., Yankner B.A., He X. beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci U S A 1999, 96:6273-6278.
75. Marikawa Y., Elinson R.P. beta-TrCP is a negative regulator of Wnt/beta-catenin signaling pathway and dorsal axis formation in Xenopus embryos. Mech Dev 1998, 77:75-80.
76. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275:1784-1787.
77. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
78. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 2002, 22:1184-1193.
79. Letamendia A., Labbe E., Attisano L. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 2001, 83-A(Suppl. 1):S31-S39.
80. Theil T., Aydin S., Koch S., Grotewold L., Ruther U. Wnt and Bmp signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. Development 2002, 129:3045-3054.